Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Douglas Taylor

Showing results (21-30 of 58) with videos related to

Pageof 6
Sort By:
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|January 6, 2016
Cost-effectiveness of linaclotide compared to antidepressants in the treatment of irritable bowel syndrome with constipation in ScotlandMark Fisher, Andrew Walker, Meritxell Falqués, et al.
Contraception: X|October 12, 2023
A randomized crossover study to evaluate local tolerability following subcutaneous administration of a new depot medroxyprogesterone acetate contraceptive formulationVera Halpern, Angie Wheeless, Vivian Brache, et al.
Fertility and Sterility|January 24, 2021
Clinical trial to evaluate pharmacokinetics and pharmacodynamics of medroxyprogesterone acetate after subcutaneous administration of Depo-ProveraVera Halpern, Vivian Brache, Douglas Taylor, et al.
Transfusion|August 1, 2012
Coagulation profile of liquid-state plasmaRobert C Gosselin, Carol Marshall, Denis M Dwyre, et al.
Contraception: X|September 30, 2020
Levonorgestrel release rates measured through analysis of two-rod contraceptive explantsRachael Fuchs, Douglas Taylor, David W Jenkins, et al.
Contraception|March 15, 2016
Medroxyprogesterone acetate levels among Kenyan women using depot medroxyprogesterone acetate in the FEM-PrEP trialKavita Nanda, Rebecca Callahan, Douglas Taylor, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 16, 2015
Pregnancy and contraceptive use among women participating in the FEM-PrEP trialRebecca Callahan, Kavita Nanda, Saidi Kapiga, et al.
Lab on a Chip|June 3, 2010
Better shrinkage than Shrinky-DinksDiep Nguyen, Douglas Taylor, Kun Qian, et al.
Contraception: X|November 8, 2021
Suppression of ovulation and pharmacokinetics following subcutaneous administration of various doses of Depo-Provera®: a randomized trialVera Halpern, Rachael Fuchs, Vivian Brache, et al.
Contraception|July 6, 2015
In vivo release of levonorgestrel from Sino-implant (II) — an innovative comparison of explant dataRebecca L Callahan, Douglas Taylor, David W Jenkins, et al.
Pageof 6

Showing results (21-30 of 58) with videos related to

Sort By:
Pageof 6
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|January 6, 2016
Cost-effectiveness of linaclotide compared to antidepressants in the treatment of irritable bowel syndrome with constipation in ScotlandMark Fisher, Andrew Walker, Meritxell Falqués, et al.
Contraception: X|October 12, 2023
A randomized crossover study to evaluate local tolerability following subcutaneous administration of a new depot medroxyprogesterone acetate contraceptive formulationVera Halpern, Angie Wheeless, Vivian Brache, et al.
Fertility and Sterility|January 24, 2021
Clinical trial to evaluate pharmacokinetics and pharmacodynamics of medroxyprogesterone acetate after subcutaneous administration of Depo-ProveraVera Halpern, Vivian Brache, Douglas Taylor, et al.
Transfusion|August 1, 2012
Coagulation profile of liquid-state plasmaRobert C Gosselin, Carol Marshall, Denis M Dwyre, et al.
Contraception: X|September 30, 2020
Levonorgestrel release rates measured through analysis of two-rod contraceptive explantsRachael Fuchs, Douglas Taylor, David W Jenkins, et al.
Contraception|March 15, 2016
Medroxyprogesterone acetate levels among Kenyan women using depot medroxyprogesterone acetate in the FEM-PrEP trialKavita Nanda, Rebecca Callahan, Douglas Taylor, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|January 16, 2015
Pregnancy and contraceptive use among women participating in the FEM-PrEP trialRebecca Callahan, Kavita Nanda, Saidi Kapiga, et al.
Lab on a Chip|June 3, 2010
Better shrinkage than Shrinky-DinksDiep Nguyen, Douglas Taylor, Kun Qian, et al.
Contraception: X|November 8, 2021
Suppression of ovulation and pharmacokinetics following subcutaneous administration of various doses of Depo-Provera®: a randomized trialVera Halpern, Rachael Fuchs, Vivian Brache, et al.
Contraception|July 6, 2015
In vivo release of levonorgestrel from Sino-implant (II) — an innovative comparison of explant dataRebecca L Callahan, Douglas Taylor, David W Jenkins, et al.
Pageof 6